vTv Therapeutics (VTVT) Profit After Tax (2014 - 2026)

vTv Therapeutics has disclosed Profit After Tax across 13 years of filings, most recently posting $24.1 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at $24.1 million, up 488.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $605000.0 (up 102.88% YoY), and the FY2025 annual result was -$27.0 million, down 46.11% from the prior year.
• Profit After Tax came in at $24.1 million for Q1 2026 at vTv Therapeutics, up from -$7.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $24.1 million in Q1 2026 to a low of -$10.3 million in Q3 2025.
• The 5-year median for Profit After Tax is -$6.0 million (2024), against an average of -$4.2 million.
• Across the five-year window, Profit After Tax slumped 572.86% in 2022 and jumped 488.19% in 2026, its largest moves.
• vTv Therapeutics' Profit After Tax stood at -$4.7 million in 2022, then advanced by 6.41% to -$4.4 million in 2023, then increased by 18.17% to -$3.6 million in 2024, then slumped by 96.42% to -$7.1 million in 2025, then jumped by 438.11% to $24.1 million in 2026.
• The last three Profit After Tax figures came in at $24.1 million (Q1 2026), -$7.1 million (Q4 2025), and -$10.3 million (Q3 2025), per Business Quant data.